President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services is one ...

Donald Trump's appointment of Robert F Kennedy Junior as health czar means interesting times for US-focused ASX life sciences ...

If confirmed as head of the Department of Health and Human Services, Kennedy could influence U.S. policy on vaccines, drugs and food safety.

Other drug manufacturers declined in the days following the nomination. Pfizer and Moderna have declined 6.9% and 6.2% ...

Trump’s selection is sounding the alarm in the public health community and leaving the biotech and pharmaceutical industries ...

The vaccine skeptic may find it hard to enact earth-shattering changes to American healthcare.

Friday was a doozy for many biotech and pharmaceutical companies after news broke late Thursday that President-elect Donald Trump would nominate vaccine skeptic Robert F. Kennedy Jr. to the nation's ...

Bavarian Nordic, with a diverse vaccine portfolio and $340 million in contracts for 2025, offers growth potential for ...

Vaccine and other healthcare stocks retreated sharply on Friday after RFK was selected to lead the US health and human ...

While RFK Jr. has recently attempted to dilute his controversial vaccine beliefs, emphasizing in an interview that "we're not ...

Robert F. Kennedy's Jr. push to remove fluoride from the nation's public water supply could benefit some companies. Here's ...